2002
New Option Allows Early Intervention of Common Complication Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and...
New Platform Offers Advanced Therapy, Comprehensive Patient Management and Ease-of-Use Features Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in...
Inventors of the Implantable Defibrillator Honored by the National Inventors Hall of Fame Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...
DELIVER and ELUTES Data Continue to Support Benefit of Paclitaxel Eluting Stents Indianapolis, Ind. and Paris - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac...
Company to Hold Mid-Quarter Call Today Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today...
Indianapolis, Ind. and Paris - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that the first patient has been treated in...
Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will host an investor...
Sixth-Generation Stent System Features Enhanced Deliverability, Market-Leading Stent Design Indianapolis, Ind. and Brussels - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...
Live Webcast Available Indianapolis, Ind. - As previously announced, Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, will host a...
Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced the launch of its fifth...